ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PRM Proteome Sciences Plc

3.60
-0.13 (-3.49%)
22 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Proteome Sciences Plc LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.13 -3.49% 3.60 3.20 4.00 3.74 3.50 3.50 463,833 16:35:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 7.78M 1.33M 0.0045 8.31 11.04M
Proteome Sciences Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker PRM. The last closing price for Proteome Sciences was 3.73p. Over the last year, Proteome Sciences shares have traded in a share price range of 2.97p to 8.50p.

Proteome Sciences currently has 295,182,056 shares in issue. The market capitalisation of Proteome Sciences is £11.04 million. Proteome Sciences has a price to earnings ratio (PE ratio) of 8.31.

Proteome Sciences Share Discussion Threads

Showing 157551 to 157574 of 157575 messages
Chat Pages: 6303  6302  6301  6300  6299  6298  6297  6296  6295  6294  6293  6292  Older
DateSubjectAuthorDiscuss
22/5/2024
16:33
What has it to do with Northants James. Are the team being stroke tested? Or perhaps they are testing them for 'mad cow disease' or more likely 'mad goat disease'?
dominiccummings
22/5/2024
12:36
I can say with 100% certainty,they weren't mentioned,and no I didn't watch it.
peverill
22/5/2024
09:28
Mixed emotions for head coach Sadler as Northants are denied by Derbyshire
By Jeremy Casey
Published 21st May 2024, 07:14 BST

John Sadler admitted to a sense of dejection but also pride in his team's performance as Northants were denied a first Vitality County Championship Division Two victory of the season on a dramatic final day against Derbyshire on Monday.
Facing a victory target of 371 after Emilio Gay, with a stunning 153 not out from 161 balls, and Karun Nair (55) had powered the County to a morning declaration on 301 for three, the home side dug in to rally brilliantly from sliding to 149 for seven at tea.

From looking as if they were heading for certain defeat, they held out for the next 41 overs to finish on 261 for nine and seal the draw, with Zak Chappell going on the offensive to hit 72 from 101 balls, and Anuj Dal blocking his way to 31 not out from 131 balls.


Two late wickets did give Northants hope, and in the final over of the day Daj did nick a Ben Sanderson delivery, but the ball flew agonosingly between a gap in the six-strong slip cordon and the game was up.

For Northants, Rob Keogh starred with the ball, claiming five for 62 to add to his first innings century, while loan man Liam Patterson-White took three for 58 from 29 overs.

barry evans
22/5/2024
09:26
10/05/2024
12:00
PRBB Auditorium
PRBB-CRG Sessions
Steven Gygi
Harvard Medical School
"Proteomics as a biological assay"
Host: Eduard Sabido
Abstract:Proteomics is the systematic analysis of proteins for their various properties including expression levels, modification state, structure, interaction partners, function, and many more. For protein expression profiling, the combination of mass spectrometry with sample multiplexing creates a unique biological assay where replicates, positive and negative controls, as well as all treatment conditions can be measured in a single experiment. Tandem mass tags (TMT) facilitate these analyses and will soon be available as a 32plex reagent set. In this talk, I will highlight several new advances with these reagents including their use in targeted proteomics assays. As an example, we created an assay to measure short-lived proteins and applied it to 4 human cell lines. We identified ~1000 proteins with targeted degradation resulting in half-lives of only a few hours--often in a cell-line specific manner.

pools2
21/5/2024
17:17
I received an email this morning from Amati (fund managers-small companies fund & Aim VCT fund ) inviting me to join a live meeting this morning -the topic being Proteomics.Unfortunately I only just saw the email but interesting to know if anyone here listened in & whether we were mentioned.Not sure if Amati still hold any PRM shares
base7
17/5/2024
19:30
But you let CJP and squad do it for 20 years and lap it up.They did it again yesterday,how long before enough is enough.??
peverill
17/5/2024
19:16
Where's the fun in that??
peverill
17/5/2024
17:22
#92948,

Is he talking about me?



Bar Room Monkeys: 1
Brains as Big as Brazil: 0

jeffian
17/5/2024
16:50
#92950

You don’t have to.

It is your choice.

monte1
17/5/2024
16:27
Not really theirs alone - we have to put up with their whining day after day.
small crow
17/5/2024
16:23
I think that is their business, isn’t it?
barry evans
17/5/2024
16:18
If someone's not happy, and they don't see any prospects, why don't they sell???
small crow
17/5/2024
13:55
Let's be honest,they didn't have a clue when anything was due for release or even if it would be released.A complete rabble,everything they ever licensed has been shelved.Galaxy the same and a Director of said company sat there,not a clue.Richard!!!!!what was your take on the AGM.were you pleased.??
peverill
17/5/2024
12:03
I think the outcome would have been the same for me. I've never won anything on the horses!
jeffian
17/5/2024
11:44
I think the suggestion by Pike of 'going to the Grand National' is quite possibly the must useful utterance by any PRM director ever, and one which I wish I'd heard in 2001 instead of 2024 ... the outcome of that alternative would surely have been better ...
bluemango
17/5/2024
11:40
blue, I've edited my post above after checking the webcast again.
jeffian
17/5/2024
11:34
To be fair to Randox, you simply can't rush these things. Imo 7 or 8 years is nothing. There's surely got to be much more pen-pushing, meetings and further meetings and risk assessments and further meetings before anything appears from Randox and possibly not in our lifetimes.

(Edited to correct the number of years of procrastination - thanks jeffian)

bluemango
17/5/2024
10:46
No he didn't (I watched it online; it's 25 min in). In response to a leading question submitted by a shareholder (you?!) "Will Randox release their stroke test this year?", Pike referred to it as "the perennial question which has appeared for the last 7/8 years". The response was 'we hope so', but we are not in the driving seat and Randox will not release anything until it is 'market ready' (whatever that means). He said he had no specific knowledge and Randox did not have to release any information, though he suggested you might find out more 'if you went to the Grand National'. (Randox are sponsors). He "hoped" it would appear in the second half of the year. I bet he does.

There was also a question about the latest markers for tau and the reported encouraging progress in this area. Pike said plainly that "none of the tau tests in the market infringe PRM's IP" though it was possible that some of their markers may become involved in combination with others at a later stage. So much for the "Toll Booth" eh?!

(Edited for correction following a review of the meeting)

jeffian
17/5/2024
09:30
wasjobber. What does he mean by 'this'?
dominiccummings
17/5/2024
08:15
At the AGM yesterday Ian Pike confirmed that Randox look to be releasing their stroke blood test this year!

Thanks Ian.

STRONG BUY

wasjobber
16/5/2024
22:50
re 92932 proteomespeak

It is still not a good long-term platform and significant growth looks required from here to reassure on even the gross cash position. I suggest it is in that context that current performance insight is required rather than about “customer contact” and “quotations provided”. Ahead of further balance sheet insight, an £11.2 million market cap continued avoid/sell.

shareprophets

elpirata
16/5/2024
19:13
Just watched the AGM,and it kind of explains everything and why the company is in the position it finds itself in.What an absolute bunch of amateurs.I don't think they know what's going on themselves,so where all the guff on here comes from I don't know.All them to pay plus the lab staff.Not a chance we will ever see a return here.
peverill
16/5/2024
18:24
Well, Christopher has aged a bit since I met him all those years ago.A better year ahead looks likely. Pity none of the gang want to buy some shares to back their confidence...
049balt
16/5/2024
11:46
There's a presentation on the Investormeet website at 12.00 if you're interested GRC.
jeffian
Chat Pages: 6303  6302  6301  6300  6299  6298  6297  6296  6295  6294  6293  6292  Older